Archive | TAmiRNA GmbH
TAmiRNA and Medical University of Vienna Advance Liver Surgery Safety with hepatomiR®
Monday 24th February 2025
Learn More >
TAmiRNA welcomes ISEV study highlighting need for more precise EV characterization
Thursday 16th January 2025
Learn More >
Evercyte and TAmiRNA to highlight advances in EV characterization at Precision EV forum
Friday 18th October 2024
Learn More >
TAmiRNA to highlight advances in EV characterization at GSEV meeting Hamburg
Thursday 26th September 2024
Learn More >
Evercyte, Phoenestra and TAmiRNA to highlight EVscale™ manufacturing ambitions at ASEV/CzeSEV meeting
Wednesday 11th September 2024
Learn More >
TAmiRNA to present multiomic advances at EUROTOX 2024 in Copenhagen
Tuesday 3rd September 2024
Learn More >
TAmiRNA to present miRNA biomarker advances at SSCC/SGK in Zürich
Monday 2nd September 2024
Learn More >
TAmiRNA to present EV biodistribution technology at SelectBIO Congress Rotterdam
Tuesday 18th June 2024
Learn More >
LEPTON Pharmaceuticals LTD and TAmiRNA GmbH enhance their collaboration
Thursday 6th June 2024
Learn More >
TAmiRNA RNA analysis speed and efficiency boosted by Illumina technology
Wednesday 24th April 2024
Learn More >
TAmiRNA presents innovative miRNA biomarker technologies to Japanese Pharma
Thursday 14th December 2023
Learn More >